Back to Top Skip to main content

Is exercise that’s too intensive resulting in your angina?

Navy Hospitalman Kiana Bartonsmith checks a patient’s heart rate at Naval Branch Health Clinic Kings Bay in Georgia, one of Naval Hospital Jacksonville’s six health care facilities. (U.S. Navy photo by Jacob Sippel) Navy Hospitalman Kiana Bartonsmith checks a patient’s heart rate at Naval Branch Health Clinic Kings Bay in Georgia, one of Naval Hospital Jacksonville’s six health care facilities. (U.S. Navy photo by Jacob Sippel)

Recommended Content:

Conditions and Treatments | Health Readiness | Heart Health | Preventive Health

Coronary artery disease is the most common type of heart disease and the leading cause of death in the United States for both men and women. Arteries carry oxygenated blood throughout the body including to the heart muscle. Over time, plaque can build up in the arteries, which harden and constrict blood flow to the heart. When the heart does not get enough blood, the body’s response is angina. Angina is experienced as a feeling of tightness or pressure in the chest that can also radiate out to the neck, jaw, back, or shoulders. Women may also experience nausea, shortness of breath, or fatigue. Angina can be exercise-induced or caused by other symptoms of heart disease.

“Any time the heart’s demand for oxygen is greater than the supply, there is a chance for angina,” said Dr. Jamalah Munir, a cardiologist at Fort Belvoir Community Hospital. “Angina most commonly occurs during physical exertion, such as walking quickly up a hill or flights of stairs.” Increases in blood pressure or stress, abnormally fast heart rhythms, severe illness, or anemia can also raise the risk of experiencing angina, she added.

Preventing coronary artery disease is the goal, Munir said. This means eating a whole-food, plant based diet with minimal animal products, as well as exercising regularly, sleeping well, reducing stress, and refraining from smoking.

Even with these preventive measures, exercise can induce angina even in presumably healthy individuals. “When you exercise, your heart needs more oxygen and nutrients,” said Munir. “If the demand outstrips the supply, the result is angina.”

Someone with angina would experience a dull sensation rather than a sharp pain, which typically comes on gradually during exercise and can improve with rest, she added. Nitroglycerin, a medication that relaxes the arteries and increases blood flow, can alleviate chest tightness and pressure.

“Should you experience persistent angina while at rest or at lower levels of activity, seek medical care immediately for a possible heart attack,” Munir cautioned.

The temptation might be to think that if exercise induces angina, the safest course of action would be to remain on the couch. Munir disagrees, stating that when it comes to daily exercise, it doesn’t have to be intense or done all at once. “Some people complain that they can’t make it to the gym for a full workout, but if they walk for 10 minutes after each meal, that adds up to 30 minutes a day.” Moderate exercise combined with strength training, stretching, meditation, or yoga practice is all important to cardiovascular health, she added.

A physician can test for indicators of coronary artery disease – high blood pressure, abnormal heart rhythm, or high cholesterol – that contribute to angina. Medications can stabilize or reduce these symptoms when combined with other healthy habits such as regular exercise.

“If the combination of medication and lifestyle changes isn’t effective, invasive procedures such as coronary stents and open heart bypass surgery are options to consider,” said Munir.

To protect health, especially the heart, “dietary and lifestyle modification are the cornerstone of prevention and treatment of coronary artery disease,” she added. “Incorporating small changes into your lifestyle can make a big difference.”

You also may be interested in...

DHA IPM 19-006: 2019–2020 Seasonal Influenza Vaccination Program (IVP)

Policy

This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (o), implementing instructions, assigns responsibilities, and prescribes procedures for the seasonal influenza vaccination program. • This DHA-IPM cancels and reissues DHA-IPM 18-005. • This DHA-IPM is effective immediately and will expire 12 months from the date of issue.

DHA IPM 19-003: Reserve Health Readiness Program

Policy

This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), based on the authority of References (a) through (c), and in accordance with the guidance of References (d) through (i): • Provides utilization guidance and funding requirements for the RHRP contract to supplement Reserve Component Individual Medical Readiness (IMR) and Deployment Health activities when Service organic health readiness resources are not available to meet mission requirements. • Provides utilization guidance and funding requirements for the RHRP contract for Active Duty enrolled in TRICARE Prime Remote, U.S. Coast Guard (USCG), USCG Reserves, and re-deploying DoD civilians (e.g., U.S. Army Corps of Engineers and U.S. Army Intelligence and Security Command). • Communicate procedure guidance to all DoD organizations utilizing RHRP services. • Will expire effective 12 months from the date of issue and be converted to a DHA-Procedural Instruction.

  • Identification #: 19-003
  • Date: 3/8/2019
  • Type: DHA Interim Procedures Memorandum
  • Topics: Health Readiness

DHA PI 6025.14: Active Duty Service Member (ADSM) Erythrocyte Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency and Sickle Cell Trait (SCT) Screening

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (o), establishes Defense Health Agency’s (DHA) procedures to implement Reference (d), for erythrocyte G6PD deficiency and SCT screening at the appropriate points: during entry to the Military Services (at appointment, enlistment, or induction (Reference (j)), at pre-deployment, and at other points as indicated for validation of results (per References (k), (m), and (n)).

DHA PI 6025.07: Naloxone in the MTFs

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) through (c), and in accordance with the guidance of References (d) through (h), establishes the Defense Health Agency’s (DHA) procedures for prescribing and dispensing naloxone by pharmacists in MTFs to eligible beneficiaries, upon beneficiary request, or when the pharmacist determines the beneficiary meets the established criteria for being at risk for a life-threatening opiate overdose.

DHA PI 6200.05: Force Health Protection Quality Assurance (FHPQA) Program

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (ab), establishes the procedures for the FHPQA Program as defined in Reference (z). This DHA-PI applies to: a. OSD, the Military Departments (including the United States Coast Guard (USCG) at all times, including when it is a Service in the Department of Homeland Security by agreement with that Department), the Office of the Chairman of the Joint Chiefs of Staff (CJCS) and the Joint Staff, the Combatant Commands, the Office of the Inspector General of the DoD, the Defense Agencies, the DoD Field Activities, and all other organizational entities within the DoD (referred to collectively in this DHA-PI as the “DoD Components”). b. Civilian personnel, as defined in Reference (e), and DoD contractor personnel authorized to accompany the force (CAAF), in accordance with References (j), (m), and (n), respectively.

  • Identification #: DHA PI 6200.05
  • Date: 5/2/2018
  • Type: DHA Procedural Instruction
  • Topics: Health Readiness

DoD Instruction 6200.05: Force Health Protection Quality Assurance (FHPQA) Program

Policy

This issuance establishes policy, assigns responsibilities, and defines requirements for the development and establishment of the FHPQA Program in accordance with the authority in DoD Directive (DoDD) 5124.02, Sections 731 and 738 of Public Law 108-375; Sections 1074f, 1092a, and 1073b of Title 10, United States Code; and DoDDs 6200.04 and 5136.13.

DoD Instruction 6490.13: Comprehensive Policy on Traumatic Brain Injury-Related Neurocognitive Assessments by the Military Services

Policy

This instruction establishes policy, assigns responsibilities, and prescribes standard elements, pursuant to section 722 of Public Law 111-383, requiring the implementation of a comprehensive neurocognitive assessment policy in the Military Services.

Embedded Fragment Analyses

Policy

Clarification of the Requirement for Continuation of Semi-Annual Reporting of Results of Embedded Fragment Analyses

Pre-Deployment, Deployment, and Post-Deployment Training, Screening, and Monitoring Guidance for Department of Defense Personnel Deployed to Ebola Outbreak Areas

Policy

Department of Defense (DoD) personnel (Service members and civilian employees)deployed to Centers for Disease Control and Prevention defined Ebola outbreak areas will complete pre and post-deployment screening and training requirements outlined in this memorandum and supplemented by United States Africa Command (USAFRICOM) guidance.

Detecting and Reporting DoD Cases of Ebola Virus Disease Infection

Policy

Guidance as of 17 OCT 2014 from the Department of Defese (AFHSC)for Detecting and Reporting DoD Cases of Ebola Virus Disease Infection

Influenza Surveillance Program

Policy

Sentinel Sites for the 2014-2015 Influenza Surveillance Program

DoD Instruction 1010.10: Health Promotion and Disease Prevention

Policy

This instruction reissues DoD Directive (DoDD) 1010.10 (Reference (a)) as a DoD instruction (DoDI) in accordance with the authority in DoDD 5124.02 (Reference (b)) to establish policy and assign responsibilities for health promotion and disease prevention in accordance with References (c) through (f).

  • Identification #: DoD Instruction 1010.10
  • Date: 4/28/2014
  • Type: Instructions
  • Topics: Preventive Health

Deployment Limiting Mental Disorders and Psychotrophic Medications

Policy

Policy memorandum about Deployment Limiting Mental Disorders and Psychotrophic Medications

DoD Laboratories Participating in CDC Laboratory Response Network 03-213

Policy

Department of Defense (DoD) laboratories participating in the Centers for Disease Control and Prevention-sponsored Laboratory Response Network (LRN) do so with the approval and support of their respective Military Department Surgeons General.

Medical Planning and Programming Lexicon

Policy
<< < 1 2 3 > >> 
Showing results 1 - 15 Page 1 of 3

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing: Download a PDF Reader or learn more about PDFs.